The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.
(HealthDay)—Viral infections can happen at any time, but they're more common during winter when people spend more time in close contact with others indoors.
A new study comparing siblings who were fed differently during infancy suggests that breast-feeding might be no more beneficial than bottle-feeding for 10 of 11 long-term health and well-being outcomes in children age 4 to ...
(AP) -- A vaccine against cervical cancer hasn't been all that popular for girls. It may be even a harder sell for boys now that it's been recommended for them too.
(HealthDay)—The number of Americans dying from accidental overdoses of narcotic painkillers jumped significantly from 1999 to 2011, federal health officials reported Tuesday.
(HealthDay)—Americans are living longer than ever and their life expectancy is increasing every year, federal health officials reported Monday.
The government is setting what it calls an ambitious goal for Alzheimer's disease: Development of effective ways to treat and prevent the mind-destroying illness by 2025.
(HealthDay)—Food poisoning sickens millions of Americans each year, and most outbreaks are caused by salmonella-tainted foods or norovirus, federal health officials report.
(HealthDay)—Male circumcision rates in the United States declined 10 percent between 1979 and 2010, federal health officials reported Thursday.
(HealthDay)—While U.S. water sanitation has improved, bacteria-laden drinking water continues to cause disease outbreaks, according to a report released Thursday by federal health officials.
(HealthDay)—Graphic ads depicting the ravages of smoking have generated a bigger than expected response, federal health officials said Thursday.
When it comes to flu vaccines, a federal panel says a squirt in the nose is better than a shot in the arm for young children.
The San Diego company that makes the powerful new prescription painkiller Zohydro is selling off its migraine therapy business to focus on developing abuse-resistant forms of Zohydro.
(HealthDay)—More Americans than ever are taking cholesterol-lowering medications, federal health officials reported Tuesday.
(AP) -- Federal health officials on Monday approved the first generic versions of the blockbuster drug Zyprexa, an expensive treatment for schizophrenia and bipolar mood disorder.